F10 and COVID-19: In addition to its role in coagulation, factor Xa has been proposed to increase viral infectivity by cleaving the spike protein of the SARS-CoV virus into its active components, suggesting factor Xa inhibition as a beneficial therapeutic measure for COVID-19 [3–5].